Cargando…

Evolutionary and Genetic Recombination Analyses of Coxsackievirus A6 Variants Associated with Hand, Foot, and Mouth Disease Outbreaks in Thailand between 2019 and 2022

Coxsackievirus (CV)-A6 infections cause hand, foot, and mouth disease (HFMD) in children and adults. Despite the serious public health threat presented by CV-A6 infections, our understanding of the mechanisms by which new CV-A6 strains emerge remains limited. This study investigated the molecular ep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puenpa, Jiratchaya, Saengdao, Nutsada, Khanarat, Nongkanok, Korkong, Sumeth, Chansaenroj, Jira, Yorsaeng, Ritthideach, Wanlapakorn, Nasamon, Poovorawan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863931/ https://www.ncbi.nlm.nih.gov/pubmed/36680113 http://dx.doi.org/10.3390/v15010073

Ejemplares similares

Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)

Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)

Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6, Thailand, 2012
por: Puenpa, Jiratchaya, et al.
Publicado: (2013)

Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report
por: Chatproedprai, Susheera, et al.
Publicado: (2015)

Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020
por: Puenpa, Jiratchaya, et al.
Publicado: (2020)

Human norovirus GII.4 Hong Kong variant shares common ancestry with GII.4 Osaka and emerged in Thailand in 2016
por: Chuchaona, Watchaporn, et al.
Publicado: (2021)

Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2021)

Prevalence and Characterization of Enterovirus Infections among Pediatric Patients with Hand Foot Mouth Disease, Herpangina and Influenza Like Illness in Thailand, 2012
por: Puenpa, Jiratchaya, et al.
Publicado: (2014)

Enterovirus A71 Infection, Thailand, 2017
por: Puenpa, Jiratchaya, et al.
Publicado: (2018)

Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
por: Chansaenroj, Jira, et al.
Publicado: (2023)

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

High prevalence of circulating DS-1-like human rotavirus A and genotype diversity in children with acute gastroenteritis in Thailand from 2016 to 2019
por: Pasittungkul, Siripat, et al.
Publicado: (2021)

SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study
por: Suntronwong, Nungruthai, et al.
Publicado: (2023)

Recombinant GII.Pe-GII.4 Norovirus, Thailand, 2017–2018
por: Chuchaona, Watchaporn, et al.
Publicado: (2019)

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
por: Yorsaeng, Ritthideach, et al.
Publicado: (2023)

The impact of COVID-19 and control measures on public health in Thailand, 2020
por: Yorsaeng, Ritthideach, et al.
Publicado: (2022)

Molecular Epidemiology and Evolution of Human Enterovirus Serotype 68 in Thailand, 2006–2011
por: Linsuwanon, Piyada, et al.
Publicado: (2012)

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region
por: Puenpa, Jiratchaya, et al.
Publicado: (2019)

SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020
por: Chirathaworn, Chintana, et al.
Publicado: (2020)

Large-scale outbreak of Chikungunya virus infection in Thailand, 2018–2019
por: Khongwichit, Sarawut, et al.
Publicado: (2021)

Retinoic acid receptor beta promoter methylation and risk of cervical cancer
por: Wongwarangkana, Chaninya, et al.
Publicado: (2018)

Prevalence of antibodies against seasonal influenza A and B viruses among older adults in rural Thailand: A cross-sectional study
por: Suntronwong, Nungruthai, et al.
Publicado: (2021)

Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2021)

Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2022)

Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine
por: Chansaenroj, Jira, et al.
Publicado: (2022)

Phylogenetic molecular evolution and recombination analysis of complete genome of human parechovirus in Thailand
por: Chieochansin, Thaweesak, et al.
Publicado: (2021)

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

Influenza activity in Thailand and occurrence in different climates
por: Prachayangprecha, Slinporn, et al.
Publicado: (2015)

Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants
por: Hu, Siyuan, et al.
Publicado: (2022)

Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022
por: Noisumdaeng, Pirom, et al.
Publicado: (2023)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

High prevalence of DS-1-like rotavirus infection in Thai adults between 2016 and 2019
por: Chansaenroj, Jira, et al.
Publicado: (2020)

Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

Shewanella haliotis Associated with Severe Soft Tissue Infection, Thailand, 2012
por: Poovorawan, Kittiyod, et al.
Publicado: (2013)

Climate factors influence seasonal influenza activity in Bangkok, Thailand
por: Suntronwong, Nungruthai, et al.
Publicado: (2020)

Towards the elimination of viral hepatitis in Thailand by the year 2030
por: Posuwan, Nawarat, et al.
Publicado: (2020)

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bn9pc8g578bn52lq0r3l313c4d